Incidence of Secondary Bacterial Infections Following Utilization of Tocilizumab for the Treatment of COVID-19 – A Matched Retrospective Cohort Study

INTRODUCTION: Immunosuppressive agents are theorized to target the cytokine storm syndrome in COVID-19. However, the downstream effects regarding susceptibilities to secondary infection risk remains unknown. This study seeks to determine risk differences for secondary infections among COVID-19 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Joanna L., Stroever, Stephanie J., Rondain, Patricia E., Scatena, Robyn N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213077/
https://www.ncbi.nlm.nih.gov/pubmed/34194172
http://dx.doi.org/10.4103/jgid.jgid_358_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213077/
https://www.ncbi.nlm.nih.gov/pubmed/34194172
http://dx.doi.org/10.4103/jgid.jgid_358_20

Ejemplares similares